baseline characteristics of participants presenting with or without peripheral artery disease (pad)...

10

Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Upload: virginia-reeves

Post on 18-Jan-2018

220 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

DESCRIPTION

Absolute effects of simvastatin allocation on 5-year rates of first major vascular events among participants subdivided by prior PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54

TRANSCRIPT

Page 1: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Baseline characteristics of participants presenting with or without peripheral artery disease (PAD)

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 2: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Effects of simvastatin allocation on first major coronary event, stroke, or revascularization in participants

presenting with or without peripheral artery disease

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 3: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Absolute effects of simvastatin allocation on 5-year rates of first major vascular events among participants subdivided by prior PAD

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 4: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Effects of simvastatin allocation on major vascular events in prior disease subgroups

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 5: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Effects of simvastatin allocation on first major vascular event in participants with or without PAD subdivided by other presenting features

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 6: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Effects of simvastatin allocation on first and all major vascular events in participants with or without PAD

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 7: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Effects of simvastatin allocation on first peripheral vascular event subdivided by presenting features

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 8: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

Average use of statin (study or non-study), and average plasma LDL cholesterol concentrations, during follow-up. Table online only

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 9: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

DISCUSSION

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Page 10: Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

INVITED COMMENTARYWilliam R. Hiatt

Heart Protection Study Group J Vasc Surg 2007;45:645-54

HANDS -ON WORKSHOP IN VASCULAR ULTRASOUND...Jonas Eiberg MD. PhD, Ass. Prof., Dept. Vasc Surg, Rigshospitalet, Copenhagen, Denmark ... BLM Tutor : Gaspar Mestres MD. PhD. Vascular

Endovascular Treatment of Traumatic Carotid- Jugular ... · PDF filephenomena, and a carotid-jugular fistula usually en- ... J Vasc Surg 2004;39:1335-1339 10. Patel JV, Rossbach MM,

Resumido por: Dr. Ignacio Rivera Chavarría Vascular Periférico Hospital RA Calderón Guardia Eur J Vasc Endovasc Surg 33, S1-S70 (2007)

Endovascular treatment of aorto-enteric fistula...recurrent aortoenteric fistula as a "bridge" to definitive surgical repair. (case report) J Vasc Surg.2012;55:1160-3 . Since surgical

s c u l a r Medici Journal of Vascular Benallal and ... · J Vasc Med Surg 6: 370. doi: 10.4172/2329-6925.1000370 Page 3 of 4 J Vasc Med Surg, an open access journal Volume 6 •

s c u l a r Medici Journal of Vascular Xu J Vasc Med Surg ... · J Vasc Med Surg ISSN: JVMS, an open access journal . Editorial. Open Access. ... and the use of ROCK inhibitors in

Vasc disenglindian

Ann Vasc Surg 2010;24(5)

[XLS]lib.jiangnan.edu.cnlib.jiangnan.edu.cn/fj/SCI/2010-SCI-yxyz.xls · Web viewKIDNEY BLOOD PRESS R 1420-4096 REPROD BIOL 1642-431X SEMIN VASC SURG 0895-7967 PEDIATR RADIOL 0301-0449

ÉVALUATION DES ENDOPROTHÈSES DANS LE … · Endovascular repair of thoracic aortic lesions with the Zenith TX1 and TX2 thoracic grafts: intermediate-term results. J Vasc Surg 2005;41(4):

Ann Vasc Surg 2012 Funnel Technique

Ann Vasc Surg 2010;24(6)

in the clinic Abdominal Aortic Aneurysmpresentation, therapy, and mortality of abdominal aortic aneurysm in the United States, 2001-2004. J Vasc Surg. 2007;45:891-9. [PMID: 17391899]

Vascular and Endovascular Surgery - CGS MedicareVascular and Endovascular Surgery DOI: 10.1177/153857449803200508 Vasc Endovascular Surg 1998; 32; 455 John J. Bergan, Stephen Sparks

Heart Protection Study Group J Vasc Surg 2007;45:645-54

Ann Vasc Surg 2012; 26(7)

Medical Group International Journal of Vascular Surgery ... · International Journal of Vascular Surgery ... Int J Vasc Surg Med 3(2): 033-035. ... Cardiovascular Surgery Department

Ann Vasc Surg 2012; 26(3)

Vasc Demlecture

Ann Vasc Surg 2012;26(2)

s c u l a r Medici Journal of Vascular ne o f l a n gur 10.4172/2329 ...€¦ · Research Article Open Access Menu e al J Vasc Med Surg 9 10.4172/2329-6925.1000188 2 1 0077 J Vasc

s c u l a r Medici Journal of Vascular - Open access...Research Article Open Access Gupta et al., J Vasc Med Surg 2013, 1:3e 9 10.4172/2329-6925.1000118 0 2 0///007 J Vasc Med Surg

The Evidence Is Clear in Peripheral Bypass › CRBard › media › ProductAssets › ... · Ann Vasc Surg. 2004;18(No. 2):199-206. 10. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized

論説‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥32...J Vasc Med Surg. 2015;3:203. Real clinical practice of catheter therapy for deep venous thrombosis: periprocedural and 6-month

Ann Vasc Surg 2012; 26(8)

BSC-Peri Int Vasc Surg-Cross-Walk 13DEC2016Peri Int/Vasc Surg ACCESSORIES M0014012160 ÌMÇÂ.!5\; ... 1 of 104 BSC-Peri Int Vasc Surg-Cross-Walk_13DEC2016.xlsx. Boston Scientific

Application Brochure | Vascular Surgery Quality …...J Vasc Surg 2006;44:1273-8.91. 7. Correlation of intraoperative blood flow measurement with autogenous arteriovenous fistula outcome

Ann Vasc Surg 2012;26(1)

Ann Vasc Surg 2012; 26(5)

Interventions for Dialysis Access Steal Syndromes · 2019. 3. 7. · •PAI: Proximal arterial inflow. •Ligation. Treatment Options 15 Tynan-Cuisinier. Eur J Vasc Endovasc Surg

1_Ann Vasc Surg 2011

Ann Vasc Surg TRANS 2010

Haute Autorité de Santé - Portail HAS Professionnels · Steinmetz E, Haulon S;. Perioperative evaluation of iliac ZBIS branch devices: a French multicenter study Ann Vasc Surg